A new strategy to design label-free electrochemical biosensor for ultrasensitive diagnosis of CYFRA 21-1 as a biomarker for detection of non-small cell lung cancer

被引:50
|
作者
Jafari-Kashi, Abbas [1 ]
Rafiee-Pour, Hossain-Ali [2 ]
Shabani-Nooshabadi, Mehdi [1 ,3 ]
机构
[1] Univ Kashan, Fac Chem, Dept Analyt Chem, Kashan, Iran
[2] Univ Kashan, Fac Chem, Dept Cell & Mol Biol, Kashan, Iran
[3] Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran
关键词
CYFRA21-1; Electrochemical biosensor; Lung cancer; Guanine oxidation; Label-free; COMPOSITE THIN-FILM; GRAPHENE OXIDE; DNA BIOSENSOR; NANOPARTICLES; FABRICATION; MARKER; ASSAY;
D O I
10.1016/j.chemosphere.2022.134636
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Lung cancer is one of the most dangerous cancers with high mortality rate among other cancers therefore, early detection of this cancer is very important. Many studies have been reported in ways of diagnostic lung cancer early. According to reports, one of the most important biomarkers to detect lung cancer is Cytokeratin 19 fragment 21-1 (CYFRA21-1), which is significantly related to non-small cell lung cancer, in particular, squamous cell carcinoma. Thus, finding a new method for the early diagnosis of CYFRA 21-1 (DNA target probe) is essential. In the present report, we design a novel label-free electrochemical DNA-biosensor related to the signal of guanine oxidation. The proposed DNA biosensor is fabricated by a modified glassy carbon electrode (GCE) with reduced-graphene oxide (rGO), poly pyrrole (PPy), silver nanoparticles (AgNPs) and single-strand DNA (ssDNA as capture probe) GCE/rGO/PPy/AgNPs/ssDNA. The differential pulse voltammetry (DPV) and cyclic voltammetry (CV) techniques are used to verify the hybridization process between capture and target probes. Electrochemical impedance spectroscopy (EIS), energy diffraction X-ray (EDX) and field-emission scanning microscopy (FE-SEM) techniques are applied to the characterization of different modified GCE surfaces as well as Xray diffraction (XRD) for graphene oxide synthesis. The XRD pattern of the synthesized GO that its diffraction peak appears at 10.2. The applied CV and DPV for the guanine oxidation are determined under optimal conditions. The label-free DNA biosensor showed a great result for the determination of CYFRA21-1 with a wide linear range from two consecutive linear relationships of peak current and CYFRA21-1 concentration were found(1.0 x 10(-14) -1.0 x 10(-10) M, R-2 = 0.9936 and 1.0 x 10(-9) -1.0 x 10(-6) M, R-2 = 0.9955). Proposed electrochemical biosensor displayed low detection limit (2.4 fM).
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Predictive and Prognostic Value of CYFRA 21-1 for Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
    Takeuchi, Akira
    Oguri, Tetsuya
    Sone, Kazuki
    Ito, Keima
    Kitamura, Yuki
    Inoue, Yoshitsugu
    Asano, Takamitsu
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Takakuwa, Osamu
    Ohkubo, Hirotsugu
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Niimi, Akio
    ANTICANCER RESEARCH, 2017, 37 (10) : 5771 - 5776
  • [42] Circulating nucleosomes and cyfra 21-1 predict early the response to chemotherapy in patients with advanced non-small cell lung cancer
    Holdenrieder, S
    Stieber, P
    von Pawel, J
    Raith, H
    Nagel, D
    Feldmann, K
    Seidel, D
    LUNG CANCER, 2005, 49 : S88 - S88
  • [43] Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer
    Kosacka, Monika
    Jankowska, Renata
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (1-2): : 33 - 37
  • [44] CYFRA 21-1 enzyme-linked immunosorbent assay - Evaluation as a tumor marker in non-small cell lung cancer
    Lai, RS
    Hsu, HK
    Lu, JY
    Ger, LP
    Lai, NS
    CHEST, 1996, 109 (04) : 995 - 1000
  • [45] Ultrasensitive electrochemical detection of CYFRA 21-1 via in-situ initiated ROP signal amplification strategy
    Lu, Jing
    Hao, Lulu
    Yang, Fei
    Liu, Yanju
    Yang, Huaixia
    Yan, Shuxun
    ANALYTICA CHIMICA ACTA, 2021, 1180
  • [46] Prognostic Significance of Tumour Marker Index Based on Preoperative CEA and CYFRA 21-1 in Non-small Cell Lung Cancer
    Tomita, Masaki
    Shimizu, Tetsuya
    Ayabe, Takanori
    Yonei, Akihiro
    Onitsuka, Toshio
    ANTICANCER RESEARCH, 2010, 30 (07) : 3099 - 3102
  • [47] Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients
    Pujol, JL
    Boher, JM
    Grenier, J
    Quantin, X
    LUNG CANCER, 2001, 31 (2-3) : 221 - 231
  • [48] The Combination of Serum Biomarkers CYFRA 21-1 and CEA in the Prognostication of Early Stage Non-Small Cell Lung Cancer (NSCLC)
    Muley, Thomas
    He, Ying
    Rolny, Vincent
    Riedlinger, Julia
    Wehnl, Birgit
    Dayyani, Farshid
    Schneider, Marc A.
    Stolp, Christa
    Dienemann, Hendrik
    Meister, Michael
    Herth, Felix
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S382 - S382
  • [49] Availability of the Serum CYFRA 21-1 Level with Resected Non-Small Cell Lung Cancer: The Detectability of Recurrence and the Prognostic Impact
    Suzuki, Mikiko
    Takamochi, Kazuya
    Oh, Shiaki
    Suzuki, Kenji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S669 - S669
  • [50] CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis
    Fu, Lei
    Wang, Rong
    Yin, Ling
    Shang, Xiaopu
    Zhang, Runtong
    Zhang, Pengjun
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2019, 34 (03): : 251 - 261